Microbot Medical's LIBERTY robotic system adopted by multiple accounts, including pivotal trial sites

Microbot Medical Inc.

LIBERTY Endovascular Robotic System won accounts in key U.S. territories, including two ACCESS-PVI trial sites.
Company to attend GEST conference in NYC from May 14-17, 2026 to expand commercial footprint.
Alon Tamir appointed VP of Sales, EMEA to lead international commercialization.
CEO cites 'strong tailwind post SIR' and expects sustained momentum through peer-to-peer communication.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-021231
form_type: 8-K
ticker: MBOT
cik: 0000883975
company_name: Microbot Medical Inc.
filed_at: 2026-05-05T23:59:59+00:00
discovered_at: 2026-05-14T18:02:33.865313+00:00
generated_at: 2026-05-14T23:42:01.740048+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-021231
json_url: https://secwatch.observer/filing/0001493152-26-021231.json
markdown_url: https://secwatch.observer/filing/0001493152-26-021231.md
text_url: https://secwatch.observer/filing/0001493152-26-021231.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226021231/0001493152-26-021231-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226021231/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-021231

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.